The multifactorial approach to ptsd in the active duty military population

Abstract

In this chapter, we discuss pharmacological and administrative approaches to the treatment of posttraumatic stress disorder (ptsd) in the military population, including treatment of comorbid substance use disorders and acting as a liaison with command. Current evidence and clinical practice guidelines support the use of SSRIs, specifically sertraline, as first-line treatment for ptsd, as well as prazosin for ptsd-associated sleep disturbances and nightmares. Benzodiazepines and non-benzodiazepine hypnotics should be avoided as they have been shown to cause harm. Administrative policies unique to the military can also pose a challenge to appropriate care and are outlined below.